Health Condition 1: R00-R99- Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified
Conditions
Interventions
Intervention1: development of microfluidic sperm sorting chamber: development of microfluidic sperm sorting chamber using 3d printer
Intervention2: development of microfluidic sperm sorting chamber: d
uidic sperm sorting chamber using 3d printer
Intervention3: microfluidic sperm sorting chamber: The microfluidic sperm sorting chamber is a non-invasive device designed to isolate high-quality sperm b
Sponsors
Dr kalpana L
Eligibility
Inclusion criteria
Inclusion criteria: Men undergoing infertility tteatment men who have normal sperm morphology and motility
Exclusion criteria
Exclusion criteria: Sperm count less than 1million/ml HIV HBsAg Syphilis
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Percentage of motile, morphologically normal sperm cells successfully isolated using the microfluidic sperm sorting chamber. Timepoint: Percentage of motile, morphologically normal sperm cells successfully isolated using the microfluidic sperm sorting chamber at 24 to 48hours after using the sorted sperm for icsi/ivf/fertilization test | — |
Secondary
| Measure | Time frame |
|---|---|
| Proportion of Target vs. Non-Target Cells: Outcome: Measure of purity, indicating the ratio of target sperm cells to non-target cells. total Number of Viable Sorted Sperm Cells Recovered:Outcome: Yield of viable sperm cells retained after sorting. Percentage of Sorted Sperm Cells Remaining Viable:Outcome: Assessment of cell viability post-sortingreservation of Sperm Functionality (Motility, Morphology, and DNA Integrity):Outcome: Evaluation of functional parameters critical for fertilization potential.onsistency and Reliability of Sorting Outcomes Across Multiple Runs:Outcome: Reproducibility of results across multiple independent experiments. Timepoint: immediately post-sorting. Immediately post-sorting. Immediately and 24 hours post-sorting. Immediately and 24 hours post-sorting. Evaluated across at least three separate experiments. | — |
Countries
India
Contacts
Public ContactDr Kalpana L
saveetha medical college and hospital
Outcome results
None listed